The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of l‐arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice
- 6 July 2006
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 20 (4) , 365-372
Abstract
The present study was carried out to investigate on the possible involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate (L-arginine/NO/cGMP) pathway in the aqueous extract of Muntingia calabura (AEMC) leaves antinociception in mice assessed by abdominal constriction test. The AEMC, obtained by soaking the dried leaves in distilled water (DH(2)O) (1 : 2; w/v) for 24 h, was prepared in concentrations of 10%, 50% and 100% that were approximately equivalent to doses of 27, 135 and 270 mg/kg, and administered subcutaneously (s.c.) 5 min after pre-treatment (s.c.) of mice with DH(2)O, L-arginine (20 mg/kg), N(G)-monomethyl-L-arginine acetate (L-NMMA; 20 mg/kg), N(G)-nitro-L-arginine methyl esters (L-NAME; 20 mg/kg), methylene blue (MB) (20 mg/kg), respectively. The AEMC was found to exhibit a concentration-dependent antinociception after pre-challenge with DH(2)O. Interestingly, pre-treatment with L-arginine was found to block significantly (P < 0.05) the AEMC antinociception but only at the highest concentration (100%) of AEMC used. On the other hand, pre-treatment with L-NAME was found to significantly (P < 0.05) enhance the low concentration but inhibit the high concentration AEMC antinociception. MB was found to significantly (P < 0.05) enhance AEMC antinociception at all concentrations used. Except for the higher concentration of AEMC used, co-treatment with L-NAME was found to insignificantly and significantly (P < 0.05) reverse the L-arginine effect when given alone or with low concentration AEMC, respectively. In addition, co-treatment with MB significantly (P < 0.05) reversed the L-arginine effect when given alone or with 10% concentration AEMC but failed to affect the activity of the rest of concentrations used. As a conclusion, this study has demonstrated the involvement of L-arginine/NO/cGMP pathway in AEMC antinociception.Keywords
This publication has 37 references indexed in Scilit:
- The in vitro Antibacterial Activity of Corchorus olitoriusand Muntingia calabura ExtractsJournal of Pharmacology and Toxicology, 2006
- Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissuesBritish Journal of Pharmacology, 2003
- Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouseLife Sciences, 2000
- Nitric Oxide Signaling in the Central Nervous SystemAnnual Review of Physiology, 1995
- Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance PPain, 1994
- Modulation of In Vivo Striatal Transmitter Release by Nitric Oxide and Cyclic GMPJournal of Neurochemistry, 1994
- Nitric oxide (NO) and nociceptive processing in the spinal cordPain, 1993
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- Plant Anticancer Agents, XLVIII. New Cytotoxic Flavonoids from Muntingia calabura RootsJournal of Natural Products, 1991
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983